Jacobi Capital Management LLC Neurocrine Biosciences Inc Transaction History

Jacobi Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$86.18 - $99.03 $10,686 - $12,279	-124 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$89.43 - $102.27 $3,219 - $3,681	36 Added 40.91%	124 $12,000
Q1 2021 May 11, 2021	BUY	$87.57 - $119.4 $5,341 - $7,283	61 Added 225.93%	88 $9,000
Q4 2020 Feb 08, 2021	BUY	$86.91 - $108.33 $956 - $1,191	11 Added 68.75%	27 $3,000
Q3 2020 Oct 30, 2020	BUY	$96.16 - $135.15 $865 - $1,216	9 Added 128.57%	16 $2,000
Q2 2020 Aug 04, 2020	SELL	$85.09 - $130.36 $388,776 - $595,614	-4,569 Reduced 99.85%	7 $1,000
Q2 2020 Jul 27, 2020	BUY	$85.09 - $130.36 $389,371 - $596,527	4,576 New	4,576 $1,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.2B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Jacobi Capital Management LLC with notifications on news.